↓ Skip to main content

Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium

Overview of attention for article published in Investigational New Drugs, March 2010
Altmetric Badge

Mentioned by

patent
5 patents

Citations

dimensions_citation
48 Dimensions

Readers on

mendeley
50 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium
Published in
Investigational New Drugs, March 2010
DOI 10.1007/s10637-010-9420-8
Pubmed ID
Authors

Deborah A. Bradley, Stephanie Daignault, Charles J. Ryan, Robert S. DiPaola, David C. Smith, Eric Small, Mitchell E. Gross, Mark N. Stein, Alice Chen, Maha Hussain

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 50 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 18%
Student > Bachelor 6 12%
Researcher 5 10%
Student > Doctoral Student 4 8%
Professor > Associate Professor 4 8%
Other 12 24%
Unknown 10 20%
Readers by discipline Count As %
Medicine and Dentistry 13 26%
Agricultural and Biological Sciences 6 12%
Biochemistry, Genetics and Molecular Biology 5 10%
Computer Science 2 4%
Immunology and Microbiology 2 4%
Other 6 12%
Unknown 16 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 October 2021.
All research outputs
#8,882,501
of 26,017,215 outputs
Outputs from Investigational New Drugs
#395
of 1,286 outputs
Outputs of similar age
#40,340
of 107,728 outputs
Outputs of similar age from Investigational New Drugs
#5
of 11 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,286 research outputs from this source. They receive a mean Attention Score of 5.0. This one is in the 39th percentile – i.e., 39% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 107,728 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.